Functional impairment in patients with major depressive disorder: the 2-year PERFORM study

Lene Hammer-Helmich,1 Josep Maria Haro,2 Bengt Jönsson,3 Audrey Tanguy Melac,4 Sylvie Di Nicola,5 Julien Chollet,6 Dominique Milea,7 Benoît Rive,8 Delphine Saragoussi4 1Real World Evidence and Epidemiology, H Lundbeck A/S, Valby, Denmark; 2Research and Teaching Unit, Parc Sanitar...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Hammer-Helmich L, Haro JM, Jönsson B, Tanguy Melac A, Di Nicola S, Chollet J, Milea D, Rive B, Saragoussi D
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2018
Materias:
Acceso en línea:https://doaj.org/article/30a3f78dbf8645ebbfd997e74cb566fa
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:30a3f78dbf8645ebbfd997e74cb566fa
record_format dspace
spelling oai:doaj.org-article:30a3f78dbf8645ebbfd997e74cb566fa2021-12-02T00:42:55ZFunctional impairment in patients with major depressive disorder: the 2-year PERFORM study1178-2021https://doaj.org/article/30a3f78dbf8645ebbfd997e74cb566fa2018-01-01T00:00:00Zhttps://www.dovepress.com/functional-impairment-in-patients-with-major-depressive-disorder-the-2-peer-reviewed-article-NDThttps://doaj.org/toc/1178-2021Lene Hammer-Helmich,1 Josep Maria Haro,2 Bengt Jönsson,3 Audrey Tanguy Melac,4 Sylvie Di Nicola,5 Julien Chollet,6 Dominique Milea,7 Benoît Rive,8 Delphine Saragoussi4 1Real World Evidence and Epidemiology, H Lundbeck A/S, Valby, Denmark; 2Research and Teaching Unit, Parc Sanitari Sant Joan de Deu, CIBERSAM, University of Barcelona, Barcelona, Spain; 3Department of Economics, Stockholm School of Economics, Stockholm, Sweden; 4Real-World Evidence and Epidemiology, Lundbeck SAS, Issy-les-Moulineaux, 5Biostatistics, Inferential, Paris, 6Clinical Operations, Lundbeck SAS, Issy-les-Moulineaux, France; 7Health Economics and Epidemiology, Lundbeck Singapore Pte. Ltd, Singapore, Singapore; 8Global Analytics, Lundbeck SAS, Issy-les-Moulineaux, France Background: The Prospective Epidemiological Research on Functioning Outcomes Related to Major depressive disorder (PERFORM) study describes the course of depressive symptoms, perceived cognitive symptoms, and functional impairment over 2 years in outpatients with major depressive disorder (MDD) and investigates the patient-related factors associated with functional impairment.Methods: This was a 2-year observational study in 1,159 outpatients with MDD aged 18–65 years who were either initiating antidepressant monotherapy or undergoing their first switch of antidepressant. Functional impairment was assessed by the Sheehan Disability Scale and the Work Productivity and Activity Impairment questionnaire. Patients assessed depression severity using the nine-item Patient Health Questionnaire and severity of perceived cognitive symptoms using the five-item Perceived Deficit Questionnaire. To investigate which patient-related factors were associated with functional impairment, univariate analyses of variance were performed to identify relevant factors that were then included in multivariate analyses of covariance at baseline, month 2, months 6 and 12 combined, and months 18 and 24 combined.Results: The greatest improvement in depressive symptoms, perceived cognitive symptoms, and functional impairment was seen immediately (within 2 months) following initiation or switch of antidepressant therapy, followed by more gradual improvement and long-term stabilization. Improvement in perceived cognitive symptoms was less marked than improvement in depressive symptoms during the acute treatment phase. Functional impairment in patients with MDD was not only associated with severity of depressive symptoms but also independently associated with severity of perceived cognitive symptoms when adjusted for depression severity throughout the 2 years of follow-up.Conclusion: These findings highlight the burden of functional impairment in MDD and the importance of recognizing and managing cognitive symptoms in daily practice. Keywords: major depressive disorder, functioning, functional impairment, depression, cognitionHammer-Helmich LHaro JMJönsson BTanguy Melac ADi Nicola SChollet JMilea DRive BSaragoussi DDove Medical Pressarticlemajor depressive disorderfunctioningfunctional impairmentdepressioncognitionNeurosciences. Biological psychiatry. NeuropsychiatryRC321-571Neurology. Diseases of the nervous systemRC346-429ENNeuropsychiatric Disease and Treatment, Vol Volume 14, Pp 239-249 (2018)
institution DOAJ
collection DOAJ
language EN
topic major depressive disorder
functioning
functional impairment
depression
cognition
Neurosciences. Biological psychiatry. Neuropsychiatry
RC321-571
Neurology. Diseases of the nervous system
RC346-429
spellingShingle major depressive disorder
functioning
functional impairment
depression
cognition
Neurosciences. Biological psychiatry. Neuropsychiatry
RC321-571
Neurology. Diseases of the nervous system
RC346-429
Hammer-Helmich L
Haro JM
Jönsson B
Tanguy Melac A
Di Nicola S
Chollet J
Milea D
Rive B
Saragoussi D
Functional impairment in patients with major depressive disorder: the 2-year PERFORM study
description Lene Hammer-Helmich,1 Josep Maria Haro,2 Bengt Jönsson,3 Audrey Tanguy Melac,4 Sylvie Di Nicola,5 Julien Chollet,6 Dominique Milea,7 Benoît Rive,8 Delphine Saragoussi4 1Real World Evidence and Epidemiology, H Lundbeck A/S, Valby, Denmark; 2Research and Teaching Unit, Parc Sanitari Sant Joan de Deu, CIBERSAM, University of Barcelona, Barcelona, Spain; 3Department of Economics, Stockholm School of Economics, Stockholm, Sweden; 4Real-World Evidence and Epidemiology, Lundbeck SAS, Issy-les-Moulineaux, 5Biostatistics, Inferential, Paris, 6Clinical Operations, Lundbeck SAS, Issy-les-Moulineaux, France; 7Health Economics and Epidemiology, Lundbeck Singapore Pte. Ltd, Singapore, Singapore; 8Global Analytics, Lundbeck SAS, Issy-les-Moulineaux, France Background: The Prospective Epidemiological Research on Functioning Outcomes Related to Major depressive disorder (PERFORM) study describes the course of depressive symptoms, perceived cognitive symptoms, and functional impairment over 2 years in outpatients with major depressive disorder (MDD) and investigates the patient-related factors associated with functional impairment.Methods: This was a 2-year observational study in 1,159 outpatients with MDD aged 18–65 years who were either initiating antidepressant monotherapy or undergoing their first switch of antidepressant. Functional impairment was assessed by the Sheehan Disability Scale and the Work Productivity and Activity Impairment questionnaire. Patients assessed depression severity using the nine-item Patient Health Questionnaire and severity of perceived cognitive symptoms using the five-item Perceived Deficit Questionnaire. To investigate which patient-related factors were associated with functional impairment, univariate analyses of variance were performed to identify relevant factors that were then included in multivariate analyses of covariance at baseline, month 2, months 6 and 12 combined, and months 18 and 24 combined.Results: The greatest improvement in depressive symptoms, perceived cognitive symptoms, and functional impairment was seen immediately (within 2 months) following initiation or switch of antidepressant therapy, followed by more gradual improvement and long-term stabilization. Improvement in perceived cognitive symptoms was less marked than improvement in depressive symptoms during the acute treatment phase. Functional impairment in patients with MDD was not only associated with severity of depressive symptoms but also independently associated with severity of perceived cognitive symptoms when adjusted for depression severity throughout the 2 years of follow-up.Conclusion: These findings highlight the burden of functional impairment in MDD and the importance of recognizing and managing cognitive symptoms in daily practice. Keywords: major depressive disorder, functioning, functional impairment, depression, cognition
format article
author Hammer-Helmich L
Haro JM
Jönsson B
Tanguy Melac A
Di Nicola S
Chollet J
Milea D
Rive B
Saragoussi D
author_facet Hammer-Helmich L
Haro JM
Jönsson B
Tanguy Melac A
Di Nicola S
Chollet J
Milea D
Rive B
Saragoussi D
author_sort Hammer-Helmich L
title Functional impairment in patients with major depressive disorder: the 2-year PERFORM study
title_short Functional impairment in patients with major depressive disorder: the 2-year PERFORM study
title_full Functional impairment in patients with major depressive disorder: the 2-year PERFORM study
title_fullStr Functional impairment in patients with major depressive disorder: the 2-year PERFORM study
title_full_unstemmed Functional impairment in patients with major depressive disorder: the 2-year PERFORM study
title_sort functional impairment in patients with major depressive disorder: the 2-year perform study
publisher Dove Medical Press
publishDate 2018
url https://doaj.org/article/30a3f78dbf8645ebbfd997e74cb566fa
work_keys_str_mv AT hammerhelmichl functionalimpairmentinpatientswithmajordepressivedisorderthe2yearperformstudy
AT harojm functionalimpairmentinpatientswithmajordepressivedisorderthe2yearperformstudy
AT jonssonb functionalimpairmentinpatientswithmajordepressivedisorderthe2yearperformstudy
AT tanguymelaca functionalimpairmentinpatientswithmajordepressivedisorderthe2yearperformstudy
AT dinicolas functionalimpairmentinpatientswithmajordepressivedisorderthe2yearperformstudy
AT cholletj functionalimpairmentinpatientswithmajordepressivedisorderthe2yearperformstudy
AT milead functionalimpairmentinpatientswithmajordepressivedisorderthe2yearperformstudy
AT riveb functionalimpairmentinpatientswithmajordepressivedisorderthe2yearperformstudy
AT saragoussid functionalimpairmentinpatientswithmajordepressivedisorderthe2yearperformstudy
_version_ 1718403484041084928